
An integrated
approach
Axiloopra's proprietary discovery engine
combines three breakthrough technologies:
High-throughput screening
Computational modeling
Targeted delivery systems
It allows us to move from target
identification to preclinical validation in
record time.
A first-in-class inhibitor
targeting a novel pathway in
solid tumors.
Oncology Neuronal diseases Infectious diseases
This early-stage program is
in the discovery phase
In the pipeline
This early-stage program is
in the discovery phase
We're actively seeking strategic partnerships to accelerate
development and expand our pipeline.